NEONC TECHNOLOGIES

neonc-technologies-logo

NEONC Technologies, Inc. (NTI) is an early-stage cancer biotechnology company focused initially on intranasal (delivery through the nose) inhalation and other nontraditional delivery of a novel, highly purified form of monoterpenes (oils from fruits & plants), alone or with other chemotherapeutics (cancer treatment chemicals) agents. It will initially be used in clinical research for first-line treatment of malignant brain cancer (gliomas) and other aggressive brain cancers, and later for the tr... eatment of lung cancer. NTI was incorporated in the State of Delaware in 2008. The Company has assembled a highly qualified management team and board of directors. NTI is developing several proprietary molecules for clinical research some of which have demonstrated significant activity (positive results) in laboratory tests; NTI is accordingly building a portfolio of intellectual property around this research. In addition, the Company has reached an agreement with a manufacturer of active pharmaceutical ingredients for the development and production of proprietary monoterpenes.

#People #Website #More

NEONC TECHNOLOGIES

Industry:
Biotechnology Health Care Manufacturing Medical Device

Founded:
2008-01-01

Address:
Woodland Hills, California, United States

Country:
United States

Website Url:
http://www.neonctech.com

Total Employee:
1+

Status:
Active

Contact:
818-971-5100

Total Funding:
150 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins


Current Employees Featured

thomas-c-chen_image

Thomas C. Chen
Thomas C. Chen Founder, Chairman, CEO & CSO @ NEONC Technologies
Founder, Chairman, CEO & CSO

not_available_image

Patrick Walters
Patrick Walters COO/CFO @ NEONC Technologies
COO/CFO

Founder


thomas-c-chen_image

Thomas C. Chen

Official Site Inspections

http://www.neonctech.com

  • Host name: 1330256.cloudwaysapps.com
  • IP address: 24.199.126.140
  • Location: Flushing United States
  • Latitude: 40.7513
  • Longitude: -73.8244
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 11355

Loading ...

More informations about "NEONC Technologies"

Main - NeOnc Technologies Holdings, Inc.

Learn more via EDGAR or NeOnc’s investor relations page at neonctech.com. READ MORE. crossing the Barrier. NeOnc is the developer of a proprietary, patented platform technology that can potentially transport pharma-based …See details»

NeOnc Tech

We would like to show you a description here but the site won’t allow us.See details»

NeOnc Technologies - Crunchbase Company Profile

NEONC Technologies, Inc. (NTI) is an early-stage cancer biotechnology company focused initially on intranasal (delivery through the nose) inhalation and other …See details»

NEONC Technologies Company Overview, Contact Details

Neonctech went public on Mar 1st '24. NeOnc Technologies Holdings (NTHI) Announces 6M Share IPO at $11.25-$13.75/sh. Mar 01, 2024 | www.investing.com. Neonctech went public on …See details»

NeOnc Technologies Holdings (NTHI) Company Profile

Ticker Symbol: NTHI: Exchange: NASDAQ: Stock Type: Common Stock: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001979414: Employer ID: 92-1954864See details»

NeOnc Technologies Expands Global Clinical Trial Network

Mar 27, 2025 For more information, visit www.neonctech.com. About CBCC Global Research CBCC Global Research is a full-service clinical Contract Research Organization (CRO) …See details»

Neonc Technologies, Inc. Company Profile | Los Angeles, CA ...

Neonc Technologies, Inc. Company Profile | Los Angeles, CA | Competitors, Financials & Contacts - Dun & BradstreetSee details»

NeOnc Technologies. Information about the issuer. . News and …

— Are you looking for the complete & verified bond data? — We have everything you need: full data on over 800 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; …See details»

Leadership - NeOnc Technologies Holdings, Inc.

Dr. Axel H. Schönthal Associate Professor, Department of Molecular Microbiology & Immunology Keck School of Medicine at University of Southern California, LA.See details»

NeOnc Technologies - Craft

NeOnc Technologies has 1 employees at their 1 location. See insights on NeOnc Technologies including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»

NEONC Technologies - LinkedIn

NEONC Technologies, Inc. (NTI) is an early-stage cancer biotechnology company focused initially on intranasal (delivery through the nose) inhalation and other non traditional delivery of a novel ...See details»

NeOnc Technologies Holdings Inc NTHI | LinkedIn

NeOnc Technologies Holdings Inc NTHI Biotechnology Research Westlake Village, California 233 followers Focuses on developing and commercializing pharma-based therapeutics and drug …See details»

NeOnc Technologies CEO and Key Executive Team | Craft.co

NeOnc Technologies's Executive Chairman is Amir F. Heshmatpour. Other executives include Allen Chiang, Nominee Director & Scientific Advisory Board Member; Patrick Walters, COO …See details»

NeOnc Technologies Expands Global Clinical Trial Network with …

Mar 27, 2025 For more information, visit www.neonctech.com. About CBCC Global Research CBCC Global Research is a full-service clinical Contract Research Organization (CRO) …See details»

NeOnc Technologies Appointments the Honorable Jimmy

Mar 25, 2025 Delshad is the former mayor of the city of Beverly Hills, and the current global ambassador for the Cedars Sinai International organization, a dedicated team that speaks …See details»

NeOnc Technologies Engages Anova Enterprises to Pursue

Mar 6, 2023 Anova Enterprises, a clinical research organization, to prepare FDA Fast Track and Rare Pediatric Designation application for NEO100 ... To learn more about NeOnc, visit …See details»

NeOnc Technologies Expands Global Clinical Trial Network with …

Mar 27, 2025 For more information, visit www.neonctech.com. About CBCC Global Research CBCC Global Research is a full-service clinical Contract Research Organization (CRO) …See details»

The Business Model Behind NeOnc Technologies - Market Realist

Jan 17, 2025 According to Grand View Research, the global technology market was valued at $1.5 trillion in 2023 and is projected to grow at a CAGR of 13.96 percent from 2024 to …See details»

NeOnc Technologies Holdings, Inc. Appoints Dr. Alan Chiang to …

Mar 25, 2025 NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors — Dr. Chaing Expands NeOnc’s Expertise in Neurosurgery and Biotechnology — …See details»

Northwestern Ontario nuclear waste storage site moves forward as …

1 day ago The Nuclear Waste Management Organization (NWMO) has chosen five vendors to design and plan Canada’s first deep geological repository — a multibillion-dollar project in …See details»